Creating Innovative Vaccine Messaging by Engaging in Patient-Centered Design with Non-Vaccinating Older Adults

通过与未接种疫苗的老年人进行以患者为中心的设计来创造创新的疫苗信息

• 批准号: 10219950
• 负责人: Aaron Michael Scherer
• 金额: $ 12.2万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-01 至 2025-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10219950
• 关键词: Accounting; Adult; Advisory Committees; Advocacy; Affect; Age; Aging; Attitude; Award; Baseline Surveys; Behavior; Behavioral Mechanisms; Cessation of life; Chronic; Clinical; Coupled; Data; Development; Development Plans; Doctor of Philosophy; Elderly; Environment; Evaluation; Focus Groups; Foundations; Goals; Health; Health Care Costs; Health Services Research; Health behavior change; Health system; Healthy People 2020; Individual; Influenza; Influenza vaccination; Interdisciplinary Study; Intervention; Iowa; Knowledge; Lead; Measures; Mentorship; Methods; Modeling; Motivation; Patients; Pilot Projects; Population; Preventive Health Services; Preventive healthcare; Process; Psychologist; Psychometrics; Pulmonary Heart Disease; Randomized; Research; Research Personnel; Resources; Risk; Sampling; Science; Secure; Site; Surveys; Testing; Text; Training; Uncertainty; United States National Institutes of Health; Universities; Vaccination; Vaccines; Work; age related; aged; base; behavior change; career; career development; cognitive interview; cost; design; economic cost; efficacy study; experimental study; health organization; healthy aging; immune function; improved; influenza infection; influenza virus vaccine; information processing; innovation; insight; lens; middle age; novel; patient oriented; psychologic; skills; social; social cognition; success; uptake; vaccination outcome; vaccine acceptance; vaccine efficacy; vaccine hesitancy; vaccine safety

PROJECT SUMMARY/ABSTRACT Candidate: Aaron Scherer, PhD is a social psychologist who utilizes insights from the psychological sciences to create innovative preventive healthcare interventions, primarily for health risks that affect adults aged ≥50. Dr. Scherer’s long-term career objective is to become an independent investigator leading multidisciplinary research teams in the design and evaluation of innovative, patient-centered interventions to optimize the delivery and utilization of preventive health services for middle-aged and older adults. Research Context: Age-associated changes in immune function and chronic conditions coupled with suboptimal influenza vaccination rates (50%) result in adults aged ≥50 accounting for 95% of the 50,000 influenza-associated deaths that occur every year. Unfortunately, vaccine messaging strategies that health organizations currently utilize to increase vaccine uptake have been ineffective and, in some cases have worsened vaccine attitudes. Motivations to satisfy psychological needs such as managing threats, reducing uncertainty, and achieve social goals may bias how people process vaccine-related information and vaccine outcomes. “Motivational fit”, an alignment with a motive that undermines adult vaccine uptake, may be a more effective mechanism of behavior change to target with vaccine interventions than current approaches. Specific Aims: 1) Identify which motives have the strongest associations with vaccine outcomes for adults aged ≥50; 2) Collaborate with vaccine-hesitant adults aged ≥50 to create influenza vaccine messages that have motivational fit; 3) Conduct a pilot study to evaluate the feasibility of a vaccine messaging efficacy study. Research Plan: To accomplish these aims, Dr. Scherer will use a national, demographically-diverse online sample of adults aged ≥50 to identify four motives that are most strongly associated with vaccine uptake (i.e., largest effect sizes) for adults aged ≥50 and test whether scales measuring these motives need to be vaccine- specific. He will then collaborate with vaccine-hesitant adults aged ≥50 to develop and test influenza vaccine messages targeting each of the four motives. Finally, he will conduct a pilot study with a clinical population to evaluate the feasibility of conducting planned efficacy studies of the motivational fit vaccine messages. Career Development Plan: Dr. Scherer will develop 1) foundational content knowledge in the aging process to engage in aging research, and expertise in 2) psychometrics; 3) patient-centered design; and 4) health services research with adults aged ≥50. Dr. Scherer’s training goals will be supported by close mentorship from an interdisciplinary team; advanced didactic coursework; and other career development opportunities. Environment: The University of Iowa offers an ideal environment for Dr. Scherer to pursue his training; with mentorship from well-established experts, additional guidance from an advisory committee, and a department dedicated to his long-term success in becoming an independent investigator in healthy aging research.

项目摘要/摘要 候选人：Aaron Scherer博士是一名社会心理学家，他利用心理科学的见解 为了创建创新的预防性医疗干预措施，主要是影响≥50岁成年人的健康风险。 Scherer博士的长期职业目标是成为领导多学科的独立研究者 设计和评估创新，以患者为中心的干预措施的研究团队，以优化 为中年和老年人提供和利用预防性卫生服务。 研究环境：与年龄相关的免疫功能和慢性病的变化与 次优影响者疫苗接种率（50％）导致年龄≥50岁的成年人，占50,000的95％ 每年都会发生影响力相关的死亡。不幸的是，健康的疫苗消息传递策略 目前使用的组织用于增加疫苗的摄取量是无效的，在某些情况下， 恶化的疫苗参加。满足心理需求的动机，例如管理威胁，减少 不确定性并实现社会目标可能会偏向人们如何处理与疫苗有关的信息和疫苗 结果。与破坏成人疫苗摄取的动机的一致性“动机拟合”可能会更多 与当前方法相比，通过疫苗干预措施将行为变化的有效机理变化。 具体目的：1）确定哪些动机与成人的疫苗结局有很强的关联 ≥50岁； 2）与年龄≥50岁的疫苗hesitant成年人合作创建影响力疫苗信息 有动机拟合； 3）进行试点研究，以评估疫苗消息传递效率研究的可行性。 研究计划：为了实现这些目标，Scherer博士将在线使用国家人口统计学多样性 年龄≥50岁的成年人的样本，以确定四种与疫苗摄取最密切相关的动机（即 年龄≥50岁的成年人的最大效应尺寸，并测试测量这些动机的量表是否需要是疫苗 具体的。然后，他将与年龄≥50岁的疫苗含量成年人合作开发和测试影响力疫苗 针对四个动机的消息。最后，他将对临床人群进行试点研究 评估对动机拟合疫苗信息进行计划有效性研究的可行性。 职业发展计划：Scherer博士将开发1）在衰老过程中的基础知识 从事衰老研究和专业知识2）心理计量学； 3）以患者为中心的设计； 4）健康 与≥50岁的成年人的服务研究。 Scherer博士的培训目标将得到密切指导的支持 来自跨学科团队；高级教学课程；和其他职业发展机会。 环境：爱荷华大学为Scherer博士接受培训提供了理想的环境；和 拥有良好专家的遗产，咨询委员会的其他指导和部门 致力于他在健康衰老研究领域的独立研究者方面的长期成功。